BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 30957284)

  • 21. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 22. A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics.
    Xuan Y; Chen W; Liu K; Gao Y; Zuo S; Wang B; Ma X; Zhang X
    Dis Markers; 2021; 2021():8849977. PubMed ID: 34040677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
    J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
    White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
    Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.
    Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J
    BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
    Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
    Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Zhang D; Wang Y; Hu X
    DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
    Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
    Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic analysis and
    Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
    Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.
    Peng Y; Wu S; Xu Z; Hou D; Li N; Zhang Z; Wang L; Wang H
    Cancer Med; 2021 Aug; 10(16):5499-5512. PubMed ID: 34196116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 39.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.